"India, which lives on Sewa Paramo Dharma (service is the main duty), is engaged in vaccination development and manufacturing despite limit...

Zydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D received the Emergency Use Authorisation from the Drugs Controll...

Zydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...

The most important thing to understand about vaccines is that they teach your body how to gear up to fight an infection, without your body ...

The Indian drug regulator has given emergency use authorisation (EUA) to Zydus Cadila's three-dose Covid-19 vaccine, the ministry of scienc...

The Prime Minister tweeted saying that India is resolutely fighting the Covid battle and the approval of the world's first DNA-based vaccin...

Both the Pfizer and Moderna vaccines are mRNA vaccines, which contain tiny fragments of the genetic material known as “messenger ribonuclei...

While still in early stages, this technology has been developed rapidly by experts and if approved, the vaccine developed by India's Zydus ...

Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...

Some currently available COVID-19 vaccines rely on messenger RNA or mRNA strands to teach the human immune system to recognise the SARS-CoV...

The drug company is conducting phase-3 trials with over 20,000 participants to test whether its three-dose vaccine ZyCoV-D prevents virolog...

Dr Harsh Vardhan said, “Not each and every person in the world will be vaccinated. The prioritisation process is a dynamic process. The beh...

The company will now be initiating Phase III clinical trials in around 30,000 volunteers.

The Phase-II study of the vaccine, ZyCoV-D, had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase-I and I...

Oxford University and AstraZeneca will be sharing their data from phase-I trial of their much-touted Covid-19 vaccine candidate on July 20....

The company said in the preclinical stage the vaccine was found to be safe, immunogenic and well-tolerated. It was also able to produce neu...

Two of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...